This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bligh, H. F. J. Articles by Wolf, C. R. Search for Related Content PubMed PubMed Citation Articles by Bligh, H. F. J. Articles by Wolf, C. R.

Activation of Mitomycin C by NADPH:Cytochrome P-450 Reductase¹

Department of Molecular Biology, Kings Buildings, University of Edinburgh, Edinburgh EH9 3JR, United Kingdom [H. F. J. B., J. D. B.]; Imperial Cancer Research Fund, Molecular Pharmacology Group, Department of Biochemistry, University of Edinburgh, Edinburgh EH8 9XD, United Kingdom [A. B., C. R. W.]; Imperial Cancer Research Fund, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom [C. N. R., I. D. H.]; and McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706 [C. B. K.]

Mitomycin C is an alkylating agent used in cancer chemotherapy that shows some specificity towards hypoxic cells. The therapeutic effects of this compound are thought to result from its metabolic activation by enzymes such as NADPH:cytochrome P-450 reductase. In a previous report we described a Chinese hamster ovary cell line resistant to mitomycin C, which had a decreased NADPH:cytochrome P-450 reductase activity coupled with a lower rate of mitomycin C metabolism. In order to provide further evidence that the lower reductase activity is a factor in the resistance mechanism, we incorporated NADPH:cytochrome P-450 reductase into cytotoxicity assays and showed that it significantly sensitizes cells to mitomycin C. Also, the difference in drug sensitivity between the wild-type and drug-resistant Chinese hamster ovary cells was no longer observed. In addition to these studies, we expressed a rat liver NADPH:cytochrome P-450 reductase cDNA in a Salmonella typhimurium strain, LR5000. The bacteria expressing the rat NADPH:cytochrome P-450 reductase showed increased sensitivity to mitomycin C when incubated with this compound under aerobic conditions. However, under hypoxic conditions increased sensitivity was not observed. This parallels the previous finding with mitomycin C-resistant Chinese hamster ovary cells. These data provide direct evidence for the role of NADPH:cytochrome P-450 reductase in the cytotoxic action of this mitomycin C under aerobic but not hypoxic conditions and suggest that reduced levels of this enzyme can lead to drug resistance. P-450 reductase expressed in S. typhimurium may provide a valuable tool for evaluating the role of this enzyme in the toxicity of drugs activated through a one electron reduction pathway.

¹ This work was supported by funds from the Science and Engineering Research Council and the Imperial Cancer Research Fund. J. D. B. holds a Royal Society E.P.A. Cephalosporin Fund Senior Research Fellowship.

² On leave from the Department of Pharmaceutical Technology and Biochemistry, The Technical University of Gdansk, Poland.

³ To whom requests for reprints should be addressed, at Imperial Cancer Research Fund, Hugh Robson Building, George Square, Edinburgh EH8 9XD, United Kingdom.

Received 6/11/90. Accepted 9/10/90.

This article has been cited by other articles:

				C. Yan, J. K. Kepa, D. Siegel, I. J. Stratford, and D. Ross Dissecting the Role of Multiple Reductases in Bioactivation and Cytotoxicity of the Antitumor Agent 2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1) Mol. Pharmacol., December 1, 2008; 74(6): 1657 - 1665. [Abstract] [Full Text] [PDF]

				T. H. Ward, S. Danson, A. T. McGown, M. Ranson, N. A. Coe, G. C. Jayson, J. Cummings, R. H.J. Hargreaves, and J. Butler Preclinical Evaluation of the Pharmacodynamic Properties of 2,5-Diaziridinyl-3-Hydroxymethyl-6-Methyl-1,4-Benzoquinone Clin. Cancer Res., April 1, 2005; 11(7): 2695 - 2701. [Abstract] [Full Text] [PDF]

				M. R. Saadatzadeh, K. Bijangi-Vishehsaraei, P. Hong, H. Bergmann, and L. S. Haneline Oxidant Hypersensitivity of Fanconi Anemia Type C-deficient Cells Is Dependent on a Redox-regulated Apoptotic Pathway J. Biol. Chem., April 16, 2004; 279(16): 16805 - 16812. [Abstract] [Full Text] [PDF]

				D. Liu and D. J. Waxman Post-Transcriptional Regulation of Hepatic NADPH-Cytochrome P450 Reductase by Thyroid Hormone: Independent Effects on Poly(A) Tail Length and mRNA Stability Mol. Pharmacol., May 1, 2002; 61(5): 1089 - 1096. [Abstract] [Full Text] [PDF]

				G Pagano Redox-modulated xenobiotic action and ROS formation: a mirror or a window? Human and Experimental Toxicology, February 1, 2002; 21(2): 77 - 81. [Abstract] [PDF]

				Y. Gan, Y. Mo, J. E. Kalns, J. Lu, K. Danenberg, P. Danenberg, M. G. Wientjes, and J. L-S. Au Expression of DT-Diaphorase and Cytochrome P450 Reductase Correlates with Mitomycin C Activity in Human Bladder Tumors Clin. Cancer Res., May 1, 2001; 7(5): 1313 - 1319. [Abstract] [Full Text]

				J. L.-S. Au, R. A. Badalament, M. G. Wientjes, D. C. Young, J. A. Warner, P. L. Venema, D. L. Pollifrone, J. D. Harbrecht, J. L. Chin, S. P. Lerner, et al. Methods to Improve Efficacy of Intravesical Mitomycin C: Results of a Randomized Phase III Trial J Natl Cancer Inst, April 18, 2001; 93(8): 597 - 604. [Abstract] [Full Text] [PDF]

				H.-C. Li, D. Liu, and D. J. Waxman Transcriptional Induction of Hepatic NADPH: Cytochrome P450 Oxidoreductase by Thyroid Hormone Mol. Pharmacol., April 16, 2001; 59(5): 987 - 995. [Abstract] [Full Text]

				G. Pagano Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype Carcinogenesis, May 1, 2000; 21(5): 1067 - 1068. [Abstract] [Full Text] [PDF]

				C. Nesti, F. Trippi, R. Scarpato, L. Migliore, and G. Turchi Cytokinesis-block micronucleus assay in primary human liver fibroblasts exposed to griseofulvin and mitomycin C Mutagenesis, March 1, 2000; 15(2): 143 - 147. [Abstract] [Full Text] [PDF]

				L. G. Korkina, I. B. Deeva, A. De Biase, M. Iaccarino, R. Oral, M. Warnau, and G. Pagano Redox-dependent toxicity of diepoxybutane and mitomycin C in sea urchin embryogenesis Carcinogenesis, February 1, 2000; 21(2): 213 - 220. [Abstract] [Full Text] [PDF]

				F. A.E. Kruyt, T. Hoshino, J. M. Liu, P. Joseph, A. K. Jaiswal, and H. Youssoufian Abnormal Microsomal Detoxification Implicated in Fanconi Anemia Group C by Interaction of the FAC Protein With NADPH Cytochrome P450 Reductase Blood, November 1, 1998; 92(9): 3050 - 3056. [Abstract] [Full Text] [PDF]